Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3763099 | 0.96 | HSD17B10 (0.41) | HSD17B10CA1CA2CA9KDM4E | |
| SCHEMBL4951694 | 0.92 | HSD17B10 (0.35) | HSD17B10CA1CA2CA9KDM4E | |
| SCHEMBL12965347 | 0.90 | HSD17B10 (0.45) | HSD17B10CA1CA2CA9CYP2C9 | |
| SCHEMBL396821 | 0.87 | HSD17B10 (0.35) | HSD17B10 | |
| SCHEMBL1711725 | 0.86 | HSD17B10 (0.47) | HSD17B10KDM4EALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL12089524 | 0.85 | HSD17B10 (0.34) | HSD17B10CYP2C9MEN1KMT2ACYP1A2 | |
| SCHEMBL107339 | 0.83 | HSD17B10 (0.36) | HSD17B10SMN1; SMN2CYP2C9MEN1KMT2A | |
| SCHEMBL10019857 | 0.83 | HSD17B10 (0.36) | HSD17B10CYP2C9MEN1KMT2ACYP1A2 | |
| SCHEMBL7784272 | 0.83 | HSD17B10 (0.32) | HSD17B10CA1CA2CA9 | |
| SCHEMBL10019862 | 0.83 | HSD17B10 (0.33) | HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 881 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260112696-A1 | ELECTROLYTE SOLUTION OF LITHIUM-ION BATTERY AND LITHIUM SECONDARY BATTERY | ZHANGJIAGANG GUOTAI-HUARONG NEW CHEMICAL MATERIALS CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4607644-A1 | ELECTROLYTE SOLUTION OF LITHIUM-ION BATTERY AND LITHIUM SECONDARY BATTERY | Zhangjiagang Guotai-Huarong New Chemical Materials Co., Ltd (CN) | 2025-08-27 | — | — | EP | claimed |
| CN-117525579-B | Lithium ion battery electrolyte and lithium ion battery | 张家港市国泰华荣化工新材料有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119340480-A | Nonaqueous electrolyte and lithium secondary battery | 张家港市国泰华荣化工新材料有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119340479-A | Nonaqueous electrolyte and lithium secondary battery | 张家港市国泰华荣化工新材料有限公司 | 2025-01-21 | — | — | CN | claimed |
| EP-3315579-B1 | SURFACE TREATMENT AGENT INCLUDING PERFLUORO(POLY)ETHER GROUP-CONTAINING SILANE COMPOUND | DAIKIN IND LTD (JP) | 2024-05-01 | — | — | EP | claimed |
| WO-2024083011-A1 | ELECTROLYTE SOLUTION OF LITHIUM-ION BATTERY AND LITHIUM SECONDARY BATTERY | 张家港市国泰华荣化工新材料有限公司 | 2024-04-25 | — | — | WO | claimed |
| CN-117917792-A | Lithium ion battery electrolyte and lithium secondary battery | 张家港市国泰华荣化工新材料有限公司 | 2024-04-23 | — | — | CN | claimed |
| CN-117497858-A | Electrolyte and lithium ion battery | 蜂巢能源科技股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-114171792-B | Secondary battery electrolyte and secondary battery | 张家港市国泰华荣化工新材料有限公司 | 2023-12-05 | — | — | CN | claimed |
| US-20030083331-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2003-05-01 | — | — | US | claimed |
| US-20030032644-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2003-02-13 | — | — | US | claimed |
| US-20020165232-A1 | Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-11-07 | — | — | US | claimed |
| US-20020165231-A1 | Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-11-07 | — | — | US | claimed |
| US-6376548-B1 | FUNGICIDES; HERBICIDES; INSECTICIDES | ROHM AND HAAS COMPANY | 2002-04-23 | — | — | US | claimed |
| US-6274529-B1 | COORDINATION CATALYST CONTAINS METALLOCENE OF HAFNIUM, TITANIUM, OR ZIRCONIUM, AND HETEROCOMPOUND CONTAINING OXYGEN, NITROGEN, SULFUR, AND/OR PHOSPHORUS | ENICHEM S.P.A. (IT) | 2001-08-14 | — | — | US | claimed |
| EP-1115693-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2001029920-A1 | SHUTDOWN AND REDOX SHUTTLE ADDITIVES FOR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-04-26 | — | — | WO | claimed |
| WO-2000018721-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| EP-0771822-A1 | Catalytic system for the (co)polymerization of alpha-olefins | ENICHEM S.p.A. (IT) | 1997-05-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165231-A1 | Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, LCAT, MTTP | HSD17B10 419/4885CA1 4825/4885CA2 4562/4885 |
| US-20030083331-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, LCAT | HSD17B10 374/4885CA1 4821/4885CA2 4443/4885 |
| US-20030032644-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, PCTP | HSD17B10 257/4885CA1 4538/4885CA2 3853/4885 |
| US-20020165232-A1 | Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, DBI, PLTP | HSD17B10 553/4885CA1 4774/4885CA2 4517/4885 |
| US-20260112696-A1 | ELECTROLYTE SOLUTION OF LITHIUM-ION BATTERY AND LITHIUM SECONDARY BATTERY | KCNN2, KCNN1, HCN2 | HSD17B10 1171/4885CA1 136/4885CA2 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.